Treatment for Alopecia

Phase-Based Progress Estimates
Lahey Hospital and Medical Center, Burlington, MA
Alopecia+2 More
18 - 65
What conditions do you have?

Study Summary

A clinical trial to assess the effects and safety of PRP activated with pulsed electrical fields (PEFA-PRP) compared with unactivated PRP when used to treat AGA. The design of this small-scale, phase 1b/2a clinical trial is to demonstrate that pulsed electric field activation of autologous PRP results in a controlled release of platelet growth factors and other biologically active molecules that will have a benefit effect on the non-cycling hair follicles in the treated scalp compared to non-activated PRP. This single-center, auto-controlled study will compare the clinical benefit of PEFA-PRP versus non-activated PRP treatment of male patients with AGA.

Eligible Conditions

  • Alopecia
  • Androgenetic Alopecia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: Month 6 and Month 8

Month 8
Change in hair density and hair regrowth
Clinical progression of treatment as determined by principal investigator
Clinical progression of treatment as determined by subject
Measurement of hair regrowth

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

15 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 1 & 2

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 6 and month 8
Closest Location: Lahey Hospital and Medical Center · Burlington, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
2019First Recorded Clinical Trial
1 TrialsResearching Alopecia
59 CompletedClinical Trials

Who is running the clinical trial?

Santiste Medical Inc.Lead Sponsor
Maryanne M. Senna, MDPrincipal InvestigatorLahey Hospital & Medical Center

Eligibility Criteria

Age 18 - 65 · Male Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between 30 and 60 years of age, inclusive.
You are not a smoker and you are in good general health.
You are willing to maintain the same hair style as at the Screening Visit for the duration of the study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.